Allworth Financial’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$72.5K Buy
2,543
+52
+2% +$1.13K ﹤0.01% 2182
2026
Q1
$43.2K Buy
2,491
+439
+21% +$8.31K ﹤0.01% 2430
2025
Q4
$38.7K Buy
2,052
+26
+1% +$436 ﹤0.01% 2367
2025
Q3
$29.5K Sell
2,026
-24
-1% -$342 ﹤0.01% 2471
2025
Q2
$40.1K Buy
+2,050
New +$36.4K ﹤0.01% 2085
2023
Q2
Sell
-91
Closed -$832 3273
2023
Q1
$832 Buy
91
+31
+52% +$397 ﹤0.01% 2738
2022
Q4
$685 Buy
+60
New +$889 ﹤0.01% 2560
2022
Q3
Sell
-5
Closed 2697
2022
Q2
$0 Buy
+5
New +$139 ﹤0.01% 2432
2020
Q3
Sell
-450
Closed -$16K 1174
2020
Q2
$16K Hold
450
﹤0.01% 625
2020
Q1
$10K Hold
450
﹤0.01% 694
2019
Q4
$10K Hold
450
﹤0.01% 644
2019
Q3
$10K Buy
+450
New +$12.5K ﹤0.01% 578

Other funds holding CDNA

Allworth Financial's CDNA Position: Q2 2026 in Review

Allworth Financial increased its CareDx (CDNA) stake by 2.1% in Q2 2026, buying an estimated $1.13K and bringing the position to 2,543 shares worth $72.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2182.

Allworth Financial first reported a position in CDNA in Q3 2019 and has held it in 12 quarters since. 227 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.

  • Allworth Financial held 2,543 shares of CareDx worth $72.5K as of Q2 2026.
  • Allworth Financial bought 52 CareDx shares in Q2 2026, an estimated $1.13K.
  • CareDx made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #2182 holding.
  • Allworth Financial first reported a position in CareDx in Q3 2019 and has held it in 12 quarters since.
  • 227 funds tracked by Wall St. Rank held CareDx as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.